UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027898
Receipt number R000031966
Scientific Title The evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction using indocyanine green angiography
Date of disclosure of the study information 2017/07/01
Last modified on 2023/06/28 09:36:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction using indocyanine green angiography

Acronym

The evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction

Scientific Title

The evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction using indocyanine green angiography

Scientific Title:Acronym

The evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction

Region

Japan


Condition

Condition

Pancreatic cancer with arterial invasion

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery in pancreatectomy combined with major arterial resection/reconstruction using indocyanine green angiography

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

evaluation of blood flow in the liver/intestine and the hepatic/mesenteric artery, frequency of hepatic infarction or mesenteric ischemia

Key secondary outcomes

frequency of the postoperative complication


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

We observe the indocianine green fluoroscence flow of reconstructed aetery and hepatic/intestine after i.v. of indocianine green 2.5mg/1ml

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients undergone pancreatectomy with artery reconstruction
2) Patients with the consent of the document has been obtained from the person himself/herself to become the subject of this examination

Key exclusion criteria

1) Patient with iodinated contrast agent allergy

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Yamaue

Organization

Wakayama Medical University, School of Medicine

Division name

Second Department od Surgery

Zip code

641-8510

Address

Kimiidera 811-1, Wakayama, Japan

TEL

0734410613

Email

yamaue-h@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Kenichi
Middle name
Last name Okada

Organization

Wakayama Medical University, School of Medicine

Division name

Second Department od Surgery

Zip code

641-8510

Address

Kimiidera 811-1, Wakayama, Japan

TEL

0734410613

Homepage URL


Email

okada@wakayama-med.ac.jp


Sponsor or person

Institute

Second Department od Surgery, Wakayama Medical University, School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Second Department od Surgery, Wakayama Medical University, School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wakayama Medical University

Address

Kimiidera, 811-1, Wakayama City, Wakayama

Tel

0734410714

Email

okada@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 01 Day


Related information

URL releasing protocol

doi:10.21873/anticanres.15476

Publication of results

Published


Result

URL related to results and publications

doi:10.21873/anticanres.15476

Number of participants that the trial has enrolled

9

Results

Nine prospectively-registered consecutive patients with PNBC were enrolled, all underwent pancreatoduodenectomy with common hepatic artery en-bloc resection (PD-CHAR). We investigated the safety of PD-CHAR by blood flow evaluation with intraoperative indocyanine green fluorescence imaging in reconstructed vessels/organs. Results: Among patients who underwent PD-CHAR, there was no severe morbidity. Artery/portal vein combined resection and reconstruction was performed in all patients.

Results date posted

2023 Year 06 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 01 Month 21 Day

Baseline Characteristics

Patient with pancreatic cancer involving major artery

Participant flow

Prospective observational study

Adverse events

None

Outcome measures

Safety & feasibility

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 30 Day

Date of IRB

2017 Year 05 Month 30 Day

Anticipated trial start date

2017 Year 05 Month 30 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2021 Year 10 Month 01 Day

Date analysis concluded

2021 Year 10 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 06 Month 23 Day

Last modified on

2023 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031966


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name